Atlas Trials

Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments

Clinical trial NCT06004128 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT06004128
Sponsor
Invivyd, Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
COVID-19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.